Cardiovascular events with esaxerenone versus spironolactone in hypertension [0.03%]
高血压患者中 esaxerenone与螺内酯的心血管事件风险比较
Takashin Nakayama,Hidehiro Kaneko,Yuta Suzuki et al.
Takashin Nakayama et al.
Mineralocorticoid receptor antagonists (MRAs) exhibit distinct pharmacologic profiles, yet their differential clinical relevance remains underexplored. This study assessed cardiovascular prevention with nonsteroidal esaxerenone (ESAX) relat...
Comparative Study
Journal of human hypertension. 2026 Oct;40(10):817-823. DOI:10.1038/s41371-026-01200-2 2026
Mitofusin 2 polymorphic variants and left ventricular hypertrophy in human hypertension [0.03%]
人高血压患者中的线粒体融合蛋白2多态性和左心室肥厚关系研究
Giovanna Gallo,Giuliano Tocci,Giulia Nardoianni et al.
Giovanna Gallo et al.
Previous experimental studies showed that dysfunctions of mitofusin 2 (Mfn2), a mitochondrial dynamin-related protein, are associated with the presence of left ventricular hypertrophy (LVH). We examined the association of MFN2/rs2336384 and...
The association between mobility and asleep blood pressure alterations in frail and non-frail adults 80 years and older [0.03%]
虚弱和非虚弱的老年人出行能力与血压变化的相关性研究
Fernando G Blauth,Fernando L Scolari,Laís A S Vilar et al.
Fernando G Blauth et al.
The influence of mobility on asleep blood pressure among adults aged 80 years and older, particularly considering frailty, remains poorly understood. This cross-sectional study aimed to examine the association between objectively measured m...
Beyond ad hoc home blood pressure monitoring: The need for standardisation and integration into primary care [0.03%]
超越临时的家庭血压监测：需要标准化和与初级保健相结合
Annika Wilson,Suzanne Waddingham,Laura Sutton et al.
Annika Wilson et al.
Hypertension guidelines recommend home blood pressure monitoring (HBPM) using a standardised protocol to ensure accuracy and guide effective management. However, the extent to which HBPM is performed according to standardised protocol is un...
Addressing barriers to using fixed-dose combination antihypertensive medications: lessons from the Million Hearts initiative [0.03%]
迈向百万人心行动计划的高血压固定剂量复方制剂使用障碍及解决策略
Hilary K Wall,Margaret Meador,Nicole L Therrien
Hilary K Wall
Prevalence of hypertension in severe vs. non-severe COVID-19: a systematic review and meta-analysis [0.03%]
重症与非重症新冠肺炎患者的高血压患病率：系统评价和荟萃分析
Kanwal Khalid,Amr Adel Ahmed Abd El-Aal,Michelle Felicia Lee
Kanwal Khalid
Although numerous studies have investigated the association between hypertension and coronavirus disease 2019 (COVID-19) severity, differences in study characteristics have limited the consistency and generalizability of the available evide...
Prevalence and clinical correlates of positive aldosterone-to-renin ratio screening in obese hypertensive patients with obstructive sleep apnea: a Southeast Asian cross-sectional study [0.03%]
肥胖阻塞型睡眠呼吸暂停综合征高血压患者肾素分泌偏低的流行病学及临床特征研究：一项东南亚地区横断面研究
Huai Heng Loh,Siow Phing Tay,Ai Jiun Koa et al.
Huai Heng Loh et al.
Although routine screening for primary aldosteronism (PA) is increasingly recognized among patients with obstructive sleep apnea (OSA), data regarding aldosterone-to-renin ratio (ARR) screening positivity among Southeast Asian OSA populatio...
Why wait? the case for up-front single-pill combination therapy in stage 1 hypertension [0.03%]
为何要等？前期单片复方降压药治疗轻度高血压的依据
Benjamin D Gallagher
Benjamin D Gallagher
James E Sharman
James E Sharman
Arterial-myocardial coupling in primary light chain amyloidosis: A prospective observational study of vascular involvement [0.03%]
原发性轻链淀粉样变性患者动脉-心肌耦联功能障碍的观察研究：血管受累的表现形式
Alexandros Briasoulis,Raphael Patras,Dimitris Delialis et al.
Alexandros Briasoulis et al.
Primary light chain (AL) amyloidosis is a rare but lethal systemic disorder. Prior work suggests that vascular involvement may independently affect survival. Mechanistic data are needed to clarify its clinical role. We sought to explore vas...